Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Radiation‐induced sarcomas after radiotherapy for breast carcinoma: A large‐scale single‐institution review

Open access
Kirova, Youlia M., Vilcoq, Jacques R., Asselain, Bernard, Sastre‐Garau, Xavier, Fourquet, Alain · 2005 · Cancer

Abstract

BACKGROUND: Sarcomas are a rare complication of radiotherapy for breast carcinoma and patients have a poor prognosis. The incidence, histology, and management of patients with sarcomas were reviewed in the current study. METHODS: The authors reviewed the records of 16,705 patients with breast carcinoma. Of these, 13,472 (81%) were treated with megavoltage radiotherapy and 3233 were treated without at the Institute Curie (Paris, France) between 1981 and 1997. Median doses of 50–55 grays (Gy) in 25–27 fractions were delivered to the whole breast over a period of 5–5.5 weeks (2 Gy/day, 5 weekly fractions) followed, when indicated, by a 16–26‐Gy boost to the tumor or tumor bed. Treatment of radiation‐induced sarcomas (RIS) consisted mostly of radical surgery and chemotherapy. RESULTS: Overall, 35 patients developed sarcomas. Of these, 27 fulfilled the Cahan criteria. The median follow‐up was 9.3 years (range, 1–22.4 years). The latency period ranged from 3 years to 20.3 years. Thirteen sarcomas were located in the breast, 5– in the chest wall, 3 in the sternum, 2 in the supraclavicle, 1 in the scapula, and 3 in the axilla. Histologic evaluation identified 13 angiosarcomas, 3 osteosarcomas, 5 undifferentiated sarcomas, 1 malignant fibrous histiocytoma, 2 leiomyosarcomas, 1 fibrosarcoma, 1 rhabdomyosarcoma, and 1 myosarcoma. The cumulative RIS incidence was 0.07% (± 0.02) at 5 years, 0.27% (± 0.05) at 10 years, and 0.48% (± 0.11) at 15 years. Standardized incidence ratios were 10.2 (95% confidence interval, 9.03–11.59) for irradiated patients and 1.3 (0.3–3.6) for nonirradiated patients. Of the 27 patients, 15 died of sarcoma within 1 month to 14.5 years (mean, 34.2 ± 0.7 months). The 5‐year actuarial survival rate after diagnosis of RIS was 36% (± 0.11). CONCLUSIONS: The current study confirmed the rarity of RIS. However, it showed that the risk increased with time. Therefore, careful, long‐term follow‐up of patients treated with radiotherapy is needed for early detection and efficacious treatment of these malignancies. Cancer 2005. © 2005 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.21223

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 67

  1. Blichert‐Toft M, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life table analysis, J Natl Cancer Inst Monogr., 11, 19
  2. 10.1016/S0140-6736(00)02263-7 · DOI · Paper page
  3. 10.1016/S0960-9776(98)90096-0 · doi:10.1016/s0960-9776(98)90096-0
  4. 10.1002/1097-0142(19820301)49:5<878::AID-CNCR2820490510>3.0.CO;2-R · doi:10.1002/1097-0142(19820301)49:5<878::aid-cncr2820490510>3.0.co;2-r
  5. 10.1002/1097-0142(197912)44:6<2044::AID-CNCR2820440614>3.0.CO;2-U · doi:10.1002/1097-0142(197912)44:6<2044::aid-cncr2820440614>3.0.co;2-u
  6. Beck A, 1922, Zur Frage des Rontgenosarcomas Zugleich ein Beitrag zur Pathogenese des Sarcomas, Munch Med Wochenschr., 69, 623
  7. Brenin CM, 2002, Radiation‐induced sarcoma following treatment of breast cancer, Cancer Control., 5, 425
  8. 10.1159/000227192 · doi:10.1159/000227192
  9. 10.1200/JCO.1995.13.3.603 · DOI
  10. 10.1016/S0344-0338(11)80788-0 · doi:10.1016/s0344-0338(11)80788-0
  11. De Vathaire F, 1995, Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation, C R Acad Sci III., 318, 483
  12. 10.1002/1097-0142(19840115)53:2<232::AID-CNCR2820530208>3.0.CO;2-F · doi:10.1002/1097-0142(19840115)53:2<232::aid-cncr2820530208>3.0.co;2-f
  13. 10.1038/sj.bmt.1702381 · doi:10.1038/sj.bmt.1702381
  14. 10.1001/archsurg.1936.01190030078004 · doi:10.1001/archsurg.1936.01190030078004
  15. 10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7 · DOI · Paper page
  16. 10.1016/0360-3016(91)90783-Z · DOI · Paper page
  17. 10.1016/S0360-3016(01)02799-7 · doi:10.1016/s0360-3016(01)02799-7
  18. 10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K · doi:10.1002/1097-0142(20010701)92:1<172::aid-cncr1306>3.0.co;2-k
  19. 10.1016/S0959-8049(98)00319-0 · doi:10.1016/s0959-8049(98)00319-0
  20. 10.1038/sj.bjc.6690726 · DOI
  21. 10.1016/S0360-3016(98)00537-9 · doi:10.1016/s0360-3016(98)00537-9
  22. 10.1016/S0002-9610(02)00943-1 · doi:10.1016/s0002-9610(02)00943-1
  23. 10.1023/A:1006489918700 · DOI
  24. 10.1016/0167-8140(94)90469-3 · doi:10.1016/0167-8140(94)90469-3
  25. 10.1016/0360-3016(86)90422-0 · doi:10.1016/0360-3016(86)90422-0
  26. 10.1016/0360-3016(92)90895-O · DOI · Paper page
  27. 10.1053/ejso.2000.1073 · doi:10.1053/ejso.2000.1073
  28. 10.1002/1097-0142(19800715)46:2<368::AID-CNCR2820460226>3.0.CO;2-E · doi:10.1002/1097-0142(19800715)46:2<368::aid-cncr2820460226>3.0.co;2-e
  29. 10.1067/S0190-9622(03)00428-6 · doi:10.1067/s0190-9622(03)00428-6
  30. 10.1016/0167-8140(95)01663-5 · doi:10.1016/0167-8140(95)01663-5
  31. 10.1097/00000421-200212000-00014 · doi:10.1097/00000421-200212000-00014
  32. 10.1002/1097-0142(19860601)57:11<2130::AID-CNCR2820571108>3.0.CO;2-4 · doi:10.1002/1097-0142(19860601)57:11<2130::aid-cncr2820571108>3.0.co;2-4
  33. Steiner A, 1991, Angiosarcoma in a mastectomy scar following irradiation, Schweiz Med Wochenschr., 121, 429
  34. Stokkel MPM, 1995, Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma, Cancer., 6, 2965
  35. 10.1053/crad.2001.0666 · doi:10.1053/crad.2001.0666
  36. 10.1016/0360-3016(93)90184-W · doi:10.1016/0360-3016(93)90184-w
  37. 10.1002/cncr.11277 · doi:10.1002/cncr.11277
  38. International Commission on Radiation Units and Measurements (ICRU), 1999, Prescribing, recording and reporting photon beam therapy
  39. 10.1016/0167-8140(91)90160-I · doi:10.1016/0167-8140(91)90160-i
  40. 10.1016/j.ijrobp.2004.08.051 · DOI
  41. Breslow NE, 1980, Statistical methods in cancer research. Volume I: the analysis of case control studies, IARC Sci Publ., 32, 3
  42. Remontet L, 2003, Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000 [Evolution of cancer incidence and mortality in France from 1978 to 2000]
  43. 10.1002/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W · doi:10.1002/1097-0142(194805)1:1<64::aid-cncr2820010105>3.0.co;2-w
  44. 10.1054/brst.1999.0056 · doi:10.1054/brst.1999.0056
  45. Dowd SB, 1994, The practice of radiologic sciences, Radiol Technol., 66, 25
  46. 10.2307/3577175 · doi:10.2307/3577175
  47. Ishimaru M, 1975, A review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. Biological effects. Leukemia and related disorders, J Radiat Res., 16, S89
  48. Tubiana M, 1983, Cancers par nuisance thérapeutiques: cancers et radiothérapie [Cancers caused by therapeutic noxae: cancer and radiotherapy], Bull Cancer., 70, 47
  49. 10.1002/1097-0142(19881115)62:10<2145::AID-CNCR2820621014>3.0.CO;2-O · doi:10.1002/1097-0142(19881115)62:10<2145::aid-cncr2820621014>3.0.co;2-o
  50. 10.1002/1097-0142(19910801)68:3<524::AID-CNCR2820680313>3.0.CO;2-E · doi:10.1002/1097-0142(19910801)68:3<524::aid-cncr2820680313>3.0.co;2-e
  51. 10.1002/1097-0142(197807)42:1<118::AID-CNCR2820420120>3.0.CO;2-2 · doi:10.1002/1097-0142(197807)42:1<118::aid-cncr2820420120>3.0.co;2-2
  52. 10.1002/1097-0142(19860201)57:3<610::AID-CNCR2820570336>3.0.CO;2-P · doi:10.1002/1097-0142(19860201)57:3<610::aid-cncr2820570336>3.0.co;2-p
  53. 10.1259/bjr.70.832.9166083 · doi:10.1259/bjr.70.832.9166083
  54. Pitcher ME, 1994, Postirradiation sarcoma of soft tissue and bone, Eur J Surg Oncol., 20, 53
  55. 10.1053/crad.2000.0599 · DOI · Paper page
  56. 10.1002/1097-0142(19800315)45:6<1419::AID-CNCR2820450620>3.0.CO;2-M · doi:10.1002/1097-0142(19800315)45:6<1419::aid-cncr2820450620>3.0.co;2-m
  57. 10.1002/1097-0142(197612)38:6<2269::AID-CNCR2820380613>3.0.CO;2-7 · doi:10.1002/1097-0142(197612)38:6<2269::aid-cncr2820380613>3.0.co;2-7
  58. 10.1002/1097-0142(19900901)66:5<941::AID-CNCR2820660522>3.0.CO;2-B · doi:10.1002/1097-0142(19900901)66:5<941::aid-cncr2820660522>3.0.co;2-b
  59. 10.1093/jnci/80.4.233 · doi:10.1093/jnci/80.4.233
  60. Stout AP, 1967, Tumors of the soft tissues
  61. Harris JR, 1989, Estimating the risk of second primary tumors following cancer treatment, J Clin Oncol., 7, 5, 10.1200/JCO.1989.7.1.5 · doi:10.1200/jco.1989.7.1.5
  62. 10.1002/1097-0142(19881201)62:11<2330::AID-CNCR2820621113>3.0.CO;2-2 · doi:10.1002/1097-0142(19881201)62:11<2330::aid-cncr2820621113>3.0.co;2-2
  63. 10.1002/1097-0142(20011001)92:7<1992::AID-CNCR1719>3.0.CO;2-2 · doi:10.1002/1097-0142(20011001)92:7<1992::aid-cncr1719>3.0.co;2-2
  64. 10.1007/BF02305669 · doi:10.1007/bf02305669
  65. 10.1002/jso.2930510412 · doi:10.1002/jso.2930510412
  66. 10.1002/1097-0142(19940515)73:10<2653::AID-CNCR2820731030>3.0.CO;2-G · doi:10.1002/1097-0142(19940515)73:10<2653::aid-cncr2820731030>3.0.co;2-g
  67. 10.1002/jso.2930280304 · doi:10.1002/jso.2930280304

Cited by

See all 251

Metadata

Authors
Kirova, Y. M., Vilcoq, J. R., Asselain, B., Sastre‐Garau, X., & Fourquet, A.
Venue
Cancer
Publisher
Wiley
Published
2005-06-24
Volume
104
Issue
4
Pages
856-863
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1512462479
Cited by
251
References
6
FWCI
8.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiation‐induced sarcomas after radiotherapy for breast carcinoma: A large‐scale single‐institution review. https://app.cochat.ai/papers/10.1002/cncr.21223
The paper
Kirova, Y. M., Vilcoq, J. R., Asselain, B., Sastre‐Garau, X., & Fourquet, A. (2005). Radiation‐induced sarcomas after radiotherapy for breast carcinoma: A large‐scale single‐institution review. Cancer. https://doi.org/10.1002/cncr.21223

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.